Safety and acceptability of pneumococcal vaccinations administered in nontraditional settings

American Journal of Infection Control

Volumn 30, Issue 5, 2002, Pages 261-268

  D'Heilly, Sarah ^a   Bauman, Wendy L ^b   Nichol, Kristin L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Minnesota Visiting Nurse Agency   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; STREPTOCOCCUS VACCINE;

AGED; ARTICLE; BACTERIAL INFECTION; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; FEVER; GERIATRIC PATIENT; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; STREPTOCOCCUS INFECTION; VACCINATION;

EID: 0036334662     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1067/mic.2002.121554     Document Type: Article

References (30)

1. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance
2. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine
3. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations
4. Efficacy of pneumococcal vaccination in adults: A meta-analysis of randomized controlled trials
5. Pneumococcal vaccine: Clinical efficacy and effectiveness
6. Cost effectiveness of vaccination against pneumococcal bacteremia among elderly people
7. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
8. Adult immunization: Summary of the national vaccine advisory committee report
9. Vaccine-preventable diseases: Improving vaccination coverage in children, adolescents, and adults
10. Immunization policies and vaccine coverage among adults: The risk for missed opportunities
11. Adult immunization programs in nontraditional settings: Quality standards and guidance for program evaluation
12. Side effects associated with pneumococcal vaccination
13. Studies in human subjects of polyvalent pneumococcal vaccines
14. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants
15. Pneumococcal infection and pneumococcal vaccine
16. Simultaneous administration of influenza and pneumococcal vaccines
17. Safety of pneumococcal revaccination
18. Revaccination with pneumococal vaccine of elderly persons 6 years after primary vaccination
19. Safely of revaccination with pneumococcal polysaccharide vaccine
20. Associations of prevaccination antibody levels with adverse reactions to pneumococcal and influenza vaccines administered simultaneously in the elderly
21. Streptococcus pneumoniae polysaccharide vaccine: Age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines
22. Is there any connection between a second pneumonia shot and hospitalization among Medicare beneficiaries?
23. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly
24. Side effects associated with influenza vaccination in healthy, working adults. A randomized, placebo-controlled trial
25. Cost utility of public clinics to increase pneumococcal vaccines in the elderly